Moreover, NLRP3 inflammasome-specific inhibitors can significantly prevent respiratory inflammation and airway hyperresponsiveness in a mouse model of severe allergic asthma [26]. The gene discussed is NLRP3; the disease is airway hyperresponsiveness.